Logo del repository
  1. Home
 
Opzioni

Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.

RIZZARDI, CLARA
•
Leocata P
•
Ventura L
altro
Melato M.
2009
  • journal article

Periodico
ANTICANCER RESEARCH
Abstract
Abstract. Background: Tumor necrosis factor-relatedapoptosis-inducing ligand (TRAIL) is a recently identified death factor that acts as a potent apoptosis inducer in ameloblastomas. Materials and Methods: The expression of TRAIL and its receptors (TRAIL-R), and the location of TRAIL and its receptors (TRAIL-R), and the location ofameloblastomausing immunohistochemistry and an in situ DNA nick-end labeling method. The proliferative activity of ameloblastomas was analyzed by determining the Ki-67 labeling index.Results: TRAIL and TRAIL-R were diffusely expressed ameloblastomas, without clear correlation with the locationof apoptotic cells. Apoptosis and proliferation were opposite in the peripheral and central components of the ameloblastomas. In some ameloblastoma variants apoptosis, and proliferation seemed to modify in the same direction.Conclusion: TRAIL and its receptors might be involved in neoplastic transformation of odontogenic epithelium and might suggest some intrinsic regula
WOS
WOS:000265264000025
SCOPUS
2-s2.0-64949088230
Archivio
http://hdl.handle.net/11368/2309407
Diritti
metadata only access
Soggetti
  • apoptosis

  • ameloblastoma

Visualizzazioni
1
Data di acquisizione
Jun 8, 2022
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback